Skip to main content
Signal8

Holman Albert A III

SEC insider (Form 3/4/5 filer). CIK 0002056154. Director at Helix Acquisition Corp. II (HLXB). 1 reported Form 4/5 transaction since Sep 2024; latest on Aug 11, 2025. Located in BOSTON, MA.

Companies Holman Albert A III has filed insider reports for

  • Helix Acquisition Corp. II (HLXB): Director
Holman Albert A III profile photo

Holman Albert A III

CIK: 0002056154

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (100.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Helix Acquisition Corp. II logo
HLXB

Helix Acquisition Corp. II

Director

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • BridgeBio Oncology Therapeutics, Inc. logo
    BBOT

    BridgeBio Oncology Therapeutics, Inc.

    Aug 11, 2025
    Exercise
    Direct
    30K shares-

1-1 of 1